Doseology Sciences (FRA:VU70) Moat Score: 2/10 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VU70 Doseology Sciences Inc FRA:VU70
36 GF Score
Price €0.06
GF Value €0.10
! 5 Warning Signs
View Full Analysis

What is Doseology Sciences Moat Score?

Doseology Sciences FRA:VU70 36 Moat Score is 2 as of Jul. 19, 2026. GuruFocus rates FRA:VU70 with a GF Score™ of 36/100 and a GF Value™ of €0.10. The stock has 5 warning signs investors should review. Among 1,397 Biotechnology companies, Doseology Sciences ranks better than 58.34% on this metric.

Doseology Sciences has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Doseology Sciences has No Moat: Doseology Sciences Inc lacks significant market share, brand strength, and durable cost advantages. The company does not exhibit strong competitive advantages, resulting in a very weak position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Doseology Sciences might have No Moat - Very weak/transient advantages.

Doseology Sciences  (FRA:VU70) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Doseology Sciences Moat Score Related Terms

FRA:VU70 vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Doseology Sciences's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Doseology Sciences Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Doseology Sciences's Moat Score distribution charts can be found below:

* The bar in red indicates where Doseology Sciences's Moat Score falls into.


FRA:VU70
36GF Score
Doseology Sciences Inc FRA:VU70
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Doseology Sciences (FRA:VU70) has a Moat Score of 2 as of Jul. 19, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Doseology Sciences ranks #582 out of 1397 companies in the Biotechnology industry, placing it in the top 41.7%.
Is Doseology Sciences' Moat Score too high?
Doseology Sciences' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Doseology Sciences' value of 2 is 0% at this industry median. Based on the distribution chart, Doseology Sciences ranks #582 out of 1397 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Doseology Sciences has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Doseology Sciences' Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Doseology Sciences ranks #582 out of 1397 companies for Moat Score. This puts Doseology Sciences in the upper half of its industry. The industry median Moat Score is 2.00. Doseology Sciences' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,397 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doseology Sciences's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doseology Sciences's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doseology Sciences stock overvalued right now?
Doseology Sciences (FRA:VU70) has a current Moat Score of 2. The stock's GF Value™ is €0.10, compared to a current price of €0.06 — trading 36.5% below its estimated fair value. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Doseology Sciences' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Doseology Sciences (FRA:VU70), the current Moat Score is 2 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doseology Sciences (FRA:VU70) Overvalued in 2026?

Based on GuruFocus' analysis, Doseology Sciences stock appears to be undervalued. The current stock price of €0.06 is trading 36.5% below its estimated GF Value™ of €0.10.

Key valuation signals for FRA:VU70:

  • Moat Score: 2
  • GF Value™: €0.10 vs. price of €0.06 (36.5% below fair value)
  • GF Score™: 36/100 with 5 warning signs
  • Industry Position: 0% at the Biotechnology median (#582 of 1397)

No single metric tells the full story. See the FRA:VU70 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Doseology Sciences Business Description

Other Exchanges DOSEF:USAMOOD:Canada
Address 9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
36GF Score

Get the complete analysis for FRA:VU70

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price
€0.10
GF Value